Hypoxia-inducible factors (HIFs) are transcription factors that respond to changes in oxygen levels in the cellular environment, playing a crucial role in cellular adaptation to low oxygen conditions by regulating genes involved in angiogenesis, metabolism, and survival. These factors are essential for processes like embryonic development and tumor progression, making them significant targets for therapeutic interventions in diseases such as cancer and ischemia.